SUBSTITUTED AMIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
申请人:Elan Pharmaceuticals, Inc.
公开号:EP1430032A2
公开(公告)日:2004-06-23
EP1615892A2
申请人:——
公开号:EP1615892A2
公开(公告)日:2006-01-18
[EN] SUBSTITUTED AMINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] AMINES SUBSTITUEES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
申请人:ELAN PHARM INC
公开号:WO2003027068A2
公开(公告)日:2003-04-03
Disclosed are compounds of formula (I) which are useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
The present invention relates to compounds of formula (I) useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are also useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
Deallyloxy- and debenzyloxycarbonylation of protected alcohols, amines and thiols via a naphthalene-catalysed lithiation reaction
作者:Cherif Behloul、David Guijarro、Miguel Yus
DOI:10.1016/j.tet.2005.07.055
日期:2005.9
and Cbz-protected alcohols, amines and thiols in THF at 0 °C led, after quenching with methanol, to the recovery of the free alcohols, amines and thiols in short reaction times and with very good yields. The selectivity for the removal of the Alloc- or the Cbz- group in a polyfunctionalised substrate has been studied. The selective reductive cleavage of a benzylic carbon–oxygenbond was achieved in the